Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Baker
C Hart

Showing results (761-770 of 798) with videos related to

Pageof 80
Sort By:
ACS Medicinal Chemistry Letters|March 19, 2020
Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit TriageAmy C Hart, Lynn Abell, Junqing Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancerChenxia He, Jeanne M Danes, Peter C Hart, et al.
Neuroscience|December 31, 2018
Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral SclerosisKatherine S Yanagi, Zhijin Wu, Joshua Amaya, et al.
Critical Reviews in Eukaryotic Gene Expression|February 27, 2021
A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant ApproachChristine Finley, Matthew J Dugan, Jan Kirk Carney, et al.
The Journal of Experimental Medicine|September 2, 2015
NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1Mirza Saqib Baig, Sofia V Zaichick, Mao Mao, et al.
The International Journal of Neuropsychopharmacology|February 1, 2015
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and humanLinda M Rorick-Kehn, Jennifer W Witcher, Stephen L Lowe, et al.
Nature|March 8, 2019
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolismJiyoung Lee, Ali E Yesilkanal, Joseph P Wynne, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Nature Reviews. Genetics|June 17, 2006
A framework for community and ecosystem genetics: from genes to ecosystemsThomas G Whitham, Joseph K Bailey, Jennifer A Schweitzer, et al.
Molecular Pharmacology|March 5, 2011
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitorTerrance D Barrett, Heather L Palomino, Theresa I Brondstetter, et al.
Pageof 80

Showing results (761-770 of 798) with videos related to

Sort By:
Pageof 80
ACS Medicinal Chemistry Letters|March 19, 2020
Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit TriageAmy C Hart, Lynn Abell, Junqing Guo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancerChenxia He, Jeanne M Danes, Peter C Hart, et al.
Neuroscience|December 31, 2018
Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral SclerosisKatherine S Yanagi, Zhijin Wu, Joshua Amaya, et al.
Critical Reviews in Eukaryotic Gene Expression|February 27, 2021
A Peer-Based Strategy to Overcome HPV Vaccination Inequities in Rural Communities: A Physical Distancing-Compliant ApproachChristine Finley, Matthew J Dugan, Jan Kirk Carney, et al.
The Journal of Experimental Medicine|September 2, 2015
NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1Mirza Saqib Baig, Sofia V Zaichick, Mao Mao, et al.
The International Journal of Neuropsychopharmacology|February 1, 2015
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and humanLinda M Rorick-Kehn, Jennifer W Witcher, Stephen L Lowe, et al.
Nature|March 8, 2019
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolismJiyoung Lee, Ali E Yesilkanal, Joseph P Wynne, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine InhibitorsAmy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Nature Reviews. Genetics|June 17, 2006
A framework for community and ecosystem genetics: from genes to ecosystemsThomas G Whitham, Joseph K Bailey, Jennifer A Schweitzer, et al.
Molecular Pharmacology|March 5, 2011
Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitorTerrance D Barrett, Heather L Palomino, Theresa I Brondstetter, et al.
Pageof 80